CISD2 and hepatocellular carcinoma: In addition, DSF/Cu enhanced the cytotoxicity of sorafenib and suppressed tumor growth by inhibiting both NRF2 and MAPK signaling pathways.[88] CDGSH Iron Sulfur Domain 2 (CISD2) expression was increased in HCC cells and indicated poor patient prognosis.